NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/17/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,399.51 mln
Float141 mln
Earnings Date11/17/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-4.59
Highly reliable
1-Year Forecast
14.40
Exceptional upside
Relative Strength
90
/ 100
Top performer
Debt / Equity
0.02
Debt-free
Pre-Tax Margin
-7,756%
Severely loss-making
Business Description
Founded in 2011 and based in Vancouver, Washington, Absci Corporation is a clinical-stage company focused on discovering and developing antibody-based medicines. The company is currently advancing several drug candidates targeting conditions such as inflammatory bowel disease, hair loss, and cancer. To support its research, Absci works alongside a range of partners including Memorial Sloan Kettering Cancer Center, Twist Bioscience, Oracle Corporation, and Advanced Micro Devices.
